Steven J Burakoff, MD Email Steven Burakoff
- PROFESSOR | Oncological Sciences
- PROFESSOR | Medicine, Hematology and Medical Oncology
- PROFESSOR | Pediatrics, Hematology/Oncology
- Hospital Affiliation
- The Mount Sinai Hospital
Steven J. Burakoff, M.D., is currently the Lillian and Henry Stratton Professor of Medicine and served as Director of The Tisch Cancer Institute at the Icahn School of Medicine from 2007-2017. He is currently, Dean for Cancer Innovation and Chief, Pediatric Oncology at the Icahn School of Medicine. Prior to his appointment in 2007 to the Icahn School of Medicine, Dr. Burakoff was the Laura and Isaac Perlmutter Professor at New York University School of Medicine, the Director of the New York University Cancer Institute, and the Director of the Skirball Institute of Biomolecular Medicine.
Prior to joining the New York University School of Medicine, in 2000, he was Chair of Pediatric Oncology at the Dana-Farber Cancer Institute and the Margaret M. Dyson Professor of Pediatrics at the Harvard Medical School, and also received an Honorary Master’s of Science Degree from Harvard University. He was the recipient of the first Harvard Medical School Excellence in Mentoring Award. He was also the Ted Williams Senior Investigator at the Dana-Farber Cancer Institute, and served as a member of the Board of Trustees of the Dana-Farber Cancer Institute. Dr. Burakoff serves as a member of the External Advisory Committee of the Cold Spring Harbor Laboratory Cancer Center, University of Florida Cancer Center, and the Stony Brook Cancer Center. He is also on the Board of Directors of the Damon Runyon Cancer Foundation and he is on the Joint Scientific Advisory Board for Stand Up to Cancer.
Dr. Burakoff holds memberships in many professional societies and organizations, including: Alpha Omega Alpha, the American Society of Clinical Investigation, and the Association of American Physicians, and the American Association of Immunologist where he served as Secretary-Treasurer. He has been an Editor and Associate Editor for numerous journals and author of more than 300 publications in peer-reviewed journals. In 2009, Dr. Burakoff received the American Association of Immunologists Lifetime Achievement Award.
American Board of Internal Medicine
Multi-Disciplinary Training Areas
Cancer Biology [CAB], Immunology [IMM]
MD, Albany Medical College
MA, Queens College
MA (hon), Harvard University
, Harvard Medical School
, New York Hospital-Cornell Medical Center
, Rockefeller University
Internship, General Medicine
Cornell Medical Center
Residency, General Medicine
Cornell Medical Center
Lifetime Achievement Award
American Association of Immunologists
Lynne Cohen Foundation Awardee
Distinguished Alumnus 2003
Albany Medical College Alumni
Theobold Smith Alumni Lecture
Albany Medical College
ISI Highly Cited Researcher (1980-2000)
Laura and Isaac Perlmutter Professor
New York University, School of Medicine
Margaret M. Dyson Professor of Pediatrics
Harvard Medical School
Ted Williams Senior Investigator
Dana-Farber Cancer Institute
Association of American Physicians
Horizons in Biomedical Research Lecture
Cleveland Clinic Foundation
David A. Talmadge Lecture
Colorado Allergy Society
Major Research Interests:
1. Cellular and molecular immunology;
2. T cell activation and signal transduction;
3. Transplantation immunology.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Burakoff during 2019 and/or 2020. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
Other activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Pershing Square Sohn Award
- Pershing Square Sohn Prize
- Pfizer Inc. CTI
Scientific Advisory Board:
- American Association for Cancer Research
- Cold Spring Harbor Laboratory (CSHL)
- University of Florida Cancer Center
Service on Board of Directors: Service in a fiduciary capacity, such as an officer or director, for the following companies:
- Damon Runyon Cancer Foundation
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.